123 related articles for article (PubMed ID: 2740888)
1. A survey of current use of angiotensin-converting-enzyme inhibitors by Scottish physicians in the treatment of chronic cardiac failure.
McMurray J; Lang CC; Maclean DD; McDevitt DG; Struthers AD
Scott Med J; 1989 Apr; 34(2):425-7. PubMed ID: 2740888
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
3. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
[TBL] [Abstract][Full Text] [Related]
4. Community pharmacist outreach program directed at physicians treating congestive heart failure.
Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
[TBL] [Abstract][Full Text] [Related]
5. Differences between cardiologists and internists in the management of heart failure. Medical guidelines compared with every-day practice.
Stawicki S; Roik M; Jasik M; Kosior D; Scisło P; Kochanowski J; Dembe K; Steckiewicz R; Karnafel W; Opolski G
Kardiol Pol; 2004 Nov; 61(11):431-9; discussion 440-1. PubMed ID: 15883591
[TBL] [Abstract][Full Text] [Related]
6. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
[TBL] [Abstract][Full Text] [Related]
7. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
Sami MH
Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
[TBL] [Abstract][Full Text] [Related]
8. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.
Stafford RS; Saglam D; Blumenthal D
Arch Intern Med; 1997 Nov; 157(21):2460-4. PubMed ID: 9385297
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors in the clinical setting of chronic congestive heart failure.
Reyes AJ
Am J Cardiol; 1995 Jun; 75(18):50F-55F. PubMed ID: 7778535
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors in congestive heart failure.
Deedwania PC
Arch Intern Med; 1990 Sep; 150(9):1798-805. PubMed ID: 2132302
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitors in the treatment of heart failure.
DiBianco R
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII32-8. PubMed ID: 2189619
[TBL] [Abstract][Full Text] [Related]
12. [Management of the treatment with converting enzyme inhibitors in chronic heart failure].
Zannad F
Rev Prat; 1992 Dec; 42(20):2563-7. PubMed ID: 1299941
[TBL] [Abstract][Full Text] [Related]
13. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
[TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
Galvao M
Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
[TBL] [Abstract][Full Text] [Related]
15. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.
Chin MH; Friedmann PD; Cassel CK; Lang RM
J Gen Intern Med; 1997 Sep; 12(9):523-30. PubMed ID: 9294785
[TBL] [Abstract][Full Text] [Related]
16. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
Vlasses PH; Larijani GE; Conner DP; Ferguson RK
Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
18. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
[TBL] [Abstract][Full Text] [Related]
19. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
[TBL] [Abstract][Full Text] [Related]
20. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]